A Novel PTPN2 Isoform Differentially Regulates Immune Response.

Area of Science:

• Genetics
• Immunology
• Molecular Biology

Background:

• Genome-wide association studies link the PTPN2 gene locus to autoimmune diseases like inflammatory bowel disease (IBD).
• Identifying specific genetic variants and their functional consequences is crucial for understanding disease pathogenesis.

Purpose of the Study:

• To identify the causal genetic variant in PTPN2 associated with IBD risk.
• To elucidate the functional mechanism by which this variant contributes to disease susceptibility.
• To investigate the role of the PTPN2.4 isoform in intestinal inflammation.

Main Methods:

• Genetic fine mapping to identify the causal single-nucleotide polymorphism (SNP).
• Analysis of GTEx tissue samples and engineered myeloid cell lines.
• Mass-spectrometry to determine protein binding profiles.
• Assessment of cytokine production in human macrophages.
• Functional studies involving mutations in the nuclear export sequence (NES) of PTPN2.4.

Main Results:

• The SNP rs80262450 was identified as the putative causal variant, increasing PTPN2.4 isoform expression.
• PTPN2.4 possesses a nuclear export sequence (NES) causing cytoplasmic retention and distinct protein interactions.
• Overexpression of PTPN2.4 increased TNF-α, while its knockdown reduced pro-inflammatory cytokines in macrophages.
• Mutations in the NES motif disrupted PTPN2.4 localization and function.
• Increased PTPN2.4 expression was observed in Crohn's disease tissues.

Conclusions:

• The PTPN2.4 isoform, driven by the rs80262450 variant, is a pathogenic driver of intestinal inflammation.
• PTPN2.4 represents a novel therapeutic target for attenuating inflammation in IBD.